88 related articles for article (PubMed ID: 18574322)
1. Changes of differentiation and proliferation in k562 cells with various levels of knockdown of cationic amino acid transporter 1.
Maeda T; Shima Y; Sugiura S; Aizawa S; Tamai I
Drug Metab Pharmacokinet; 2008; 23(3):181-7. PubMed ID: 18574322
[TBL] [Abstract][Full Text] [Related]
2. L-arginine import via cationic amino acid transporter CAT1 is essential for both differentiation and proliferation of erythrocytes.
Shima Y; Maeda T; Aizawa S; Tsuboi I; Kobayashi D; Kato R; Tamai I
Blood; 2006 Feb; 107(4):1352-6. PubMed ID: 16210335
[TBL] [Abstract][Full Text] [Related]
3. Cationic amino acid transporter 1-mediated L-arginine transport at the inner blood-retinal barrier.
Tomi M; Kitade N; Hirose S; Yokota N; Akanuma S; Tachikawa M; Hosoya K
J Neurochem; 2009 Nov; 111(3):716-25. PubMed ID: 19712052
[TBL] [Abstract][Full Text] [Related]
4. Decreased proliferation and erythroid differentiation of K562 cells by siRNA-induced depression of OCTN1 (SLC22A4) transporter gene.
Nakamura T; Sugiura S; Kobayashi D; Yoshida K; Yabuuchi H; Aizawa S; Maeda T; Tamai I
Pharm Res; 2007 Sep; 24(9):1628-35. PubMed ID: 17447122
[TBL] [Abstract][Full Text] [Related]
5. Interaction of the cardiovascular risk marker asymmetric dimethylarginine (ADMA) with the human cationic amino acid transporter 1 (CAT1).
Strobel J; Mieth M; Endress B; Auge D; König J; Fromm MF; Maas R
J Mol Cell Cardiol; 2012 Sep; 53(3):392-400. PubMed ID: 22705145
[TBL] [Abstract][Full Text] [Related]
6. Arginine transport in human erythroid cells: discrimination of CAT1 and 4F2hc/y+LAT2 roles.
Rotoli BM; Closs EI; Barilli A; Visigalli R; Simon A; Habermeier A; Bianchi N; Gambari R; Gazzola GC; Bussolati O; Dall'Asta V
Pflugers Arch; 2009 Oct; 458(6):1163-73. PubMed ID: 19562367
[TBL] [Abstract][Full Text] [Related]
7. Impact of Cationic Amino Acid Transporter 1 on Blood-Retinal Barrier Transport of L-Ornithine.
Kubo Y; Obata A; Akanuma S; Hosoya K
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5925-32. PubMed ID: 26377079
[TBL] [Abstract][Full Text] [Related]
8. Analysis of cationic amino acid transport activity in canine lens epithelial cells.
Ochiai H; Moriyama J; Kanemaki N; Sato R; Onda K
Exp Anim; 2013; 62(4):311-7. PubMed ID: 24172195
[TBL] [Abstract][Full Text] [Related]
9. Rate of transport of l-arginine is independent of the expression of inducible nitric oxide synthase in HEK 293 cells.
Cui Z; Tuladhar R; Hart SL; Marber MS; Pearson JD; Baydoun AR
Nitric Oxide; 2005 Feb; 12(1):21-30. PubMed ID: 15631944
[TBL] [Abstract][Full Text] [Related]
10. Developmental changes of l-arginine transport at the blood-brain barrier in rats.
Tachikawa M; Hirose S; Akanuma SI; Matsuyama R; Hosoya KI
Microvasc Res; 2018 May; 117():16-21. PubMed ID: 29247719
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of novel mAbs against cationic amino acid transporter 1 (CAT1) on human CRC with amplified CAT1 gene.
Okita K; Hara Y; Okura H; Hayashi H; Sasaki Y; Masuko S; Kitadai E; Masuko K; Yoshimoto S; Hayashi N; Sugiura R; Endo Y; Okazaki S; Arai S; Yoshioka T; Matsumoto T; Makino Y; Komiyama H; Sakamoto K; Masuko T
Cancer Sci; 2021 Feb; 112(2):563-574. PubMed ID: 33211385
[TBL] [Abstract][Full Text] [Related]
12. The prognostic biomarker L-homoarginine is a substrate of the cationic amino acid transporters CAT1, CAT2A and CAT2B.
Chafai A; Fromm MF; König J; Maas R
Sci Rep; 2017 Jul; 7(1):4767. PubMed ID: 28684763
[TBL] [Abstract][Full Text] [Related]
13. Isolation of siRNA target by biotinylated siRNA reveals that human CCDC12 promotes early erythroid differentiation.
Fan C; Dong L; Zhu N; Xiong Y; Zhang J; Wang L; Shen Y; Zhang X; Chen M
Leuk Res; 2012 Jun; 36(6):779-83. PubMed ID: 22269669
[TBL] [Abstract][Full Text] [Related]
14. Screening of commonly prescribed drugs for effects on the CAT1-mediated transport of L-arginine and arginine derivatives.
Banjarnahor S; König J; Maas R
Amino Acids; 2022 Jul; 54(7):1101-1108. PubMed ID: 35377022
[TBL] [Abstract][Full Text] [Related]
15. The importance of cationic amino acid transporter expression in human skin.
Schnorr O; Suschek CV; Kolb-Bachofen V
J Invest Dermatol; 2003 Jun; 120(6):1016-22. PubMed ID: 12787129
[TBL] [Abstract][Full Text] [Related]
16. miR-150 inhibits terminal erythroid proliferation and differentiation.
Sun Z; Wang Y; Han X; Zhao X; Peng Y; Li Y; Peng M; Song J; Wu K; Sun S; Zhou W; Qi B; Zhou C; Chen H; An X; Liu J
Oncotarget; 2015 Dec; 6(40):43033-47. PubMed ID: 26543232
[TBL] [Abstract][Full Text] [Related]
17. Increased Cat3-mediated cationic amino acid transport functionally compensates in Cat1 knockout cell lines.
Nicholson B; Sawamura T; Masaki T; MacLeod CL
J Biol Chem; 1998 Jun; 273(24):14663-6. PubMed ID: 9614060
[TBL] [Abstract][Full Text] [Related]
18. Ferritin Heavy Subunit Silencing Blocks the Erythroid Commitment of K562 Cells via miR-150 up-Regulation and GATA-1 Repression.
Zolea F; Battaglia AM; Chiarella E; Malanga D; De Marco C; Bond HM; Morrone G; Costanzo F; Biamonte F
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039805
[TBL] [Abstract][Full Text] [Related]
19. Amino acids as modulators of endothelium-derived nitric oxide.
Kakoki M; Kim HS; Edgell CJ; Maeda N; Smithies O; Mattson DL
Am J Physiol Renal Physiol; 2006 Aug; 291(2):F297-304. PubMed ID: 16571593
[TBL] [Abstract][Full Text] [Related]
20. Enhanced erythroid cell differentiation in hypoxic condition is in part contributed by miR-210.
Sarakul O; Vattanaviboon P; Tanaka Y; Fucharoen S; Abe Y; Svasti S; Umemura T
Blood Cells Mol Dis; 2013 Aug; 51(2):98-103. PubMed ID: 23623309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
